[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351574-105":59,"doc-detail-351574-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","nos1-hypermethylation-may-participate-in-the-colorectal-cancer-development-and-be-associated-with-its-prognosis","NOS1 hypermethylation may participate in the colorectal cancer development and be associated with its prognosis","","Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, and epigenetic alterations are common, yet the specific epigenetic events driving colorectal carcinogenesis remain unclear. This study investigates NOS1 methylation, using UCSC Xena to compare expression and methylation across 33 cancer types. NOS1 promoter hypermethylation and low expression are identified in CRC, validated in two CRC datasets and extended to advanced adenomas. Genomic and methylation analyses confirm hypermethylation, while qRT-PCR supports reduced NOS1 expression. Survival analyses show NOS1 hypermethylation associates with better disease-specific outcomes, suggesting an epigenetic driver role.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nos1-hypermethylation-may-participate-in-the-colorectal-cancer-development-and-be-associated-with-its-prognosis/351574/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nos1-hypermethylation-may-participate-in-the-colorectal-cancer-development-and-be-associated-with-its-prognosis/351574.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about NOS1 in colorectal cancer?","Question",{"text":113,"@type":114},"The study examines whether NOS1 methylation participates in colorectal carcinogenesis and whether it relates to CRC prognosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was NOS1 methylation evaluated in tumor and normal tissues?",{"text":118,"@type":114},"The authors used promoter methylation assessment on genomic DNA and MassARRAY EpiTYPER methylation analysis, supported by comparative database analyses.",{"name":120,"@type":111,"acceptedAnswer":121},"What prognostic relationship does NOS1 hypermethylation show in CRC patients?",{"text":122,"@type":114},"Kaplan-Meier and Cox models indicate NOS1 hypermethylation is significantly associated with better disease-specific survival in CRC.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351574,1790165688,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","EPIGENETICS  \n2026, VOL. 21, NO. 1, 1–16  \n[https://doi.org/10.1080/15592294.2026.2660022](https://doi.org/10.1080/15592294.2026.2660022)  \nRESEARCH ARTICLE     \nNOS1 hypermethylation may participate in the colorectal cancer development and be associated with its prognosis  \nZhaohui Zhanga*, Aibuta Yeerkena*, Xinyao Shaoa*, Sangni Qiana, Shujuan Lina, Simeng Gua,b, Xiaojiang Yingc, Zhenjun Lic, Xinglin Feid, Jinhua Yangd, Mengling Tange, Jianbing Wangf, Mingjuan Jin a* and Kun Chena*  \naDepartment of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; bDepartment of Environmental Health, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China; cDepartment of Anorectal Surgery, Shaoxing People’s Hospital, Shaoxing, China; dJiashan Institute of Cancer Prevention and Treatment, Jiaxing, China; eDepartment of Public Health, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; fDepartment of Public Health, National Clinical Research Center for Child Health of the Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China  \nABSTRACT  \nColorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Although epigenetic alterations are common in CRC, the epigenetic changes that occur during colorectal carcinogenesis remain unclear. Thus, we sought to elucidate the role of NOS1 methylation in colorectal carcinogenesis, which is essential for understanding disease pathology. We used the UCSC Xena database to comparatively analyze NOS1 expression and methylation status between tumour and adjacent normal tissues across 33 cancer types. Low expression and hypermethylation of NOS1 have been identified in 12 cancer types, with CRC demonstrating this characteristic epigenetic regulation. NOS1 promoter methylation status was examined using genomic DNA extraction and MassARRAY EpiTYPER methylation analysis. NOS1 hypermethylation was confirmed among CRCs in in-house dataset 1 (p \u003C 0.001), and among CRCs and advanced adenomas in in-house dataset 2 (p \u003C 0.001) . An upward trend in methylation changes was identified from nonadvanced adenoma to advanced adenoma to CRC (p for trend \u003C 0.001). Quantitative realtime PCR was used to analyze NOS1 expression in in-house Dataset 3, and significantly low NOS1 expression was also identified in CRCs (p \u003C 0.001) . Kaplan-Meier estimator and Cox proportional hazard models were used to assess the prognostic and predictive roles of NOS1 . NOS1 hypermethylation was significantly associated with better disease-specific survival (DSS) in CRC patients. NOS1 hypermethylation is an epigenetic driver of colorectal tumorigenesis and is associated with better survival.  \nARTICLE HISTORY  \nReceived 28 August 2025 Revised 6 April 2026 Accepted 10 April 2026  \nKEYWORDS  \nColorectal cancer; colorectal adenoma; DNA methylation; NOS1; carcinogenesis  \nIntroduction  \nColorectal cancer (CRC) is a critical public health problem, as it is the third most commonly diagnosed cancer and second leading cause of cancer-related deaths worldwide [ 1]. The classical pathway of colorectal tumorigenesis is characterized by an adenoma-carcinoma sequence that may last for decades and requires the progressive accumulation of genetic and epigenetic alterations [2,3] . As malignant transformation unfolds gradually, the promising prognosis of CRC hinges on early detection and timely intervention [4] . However, despite advancements, the challenges in cancer screening and surveillance persist owing to the limitations of existing biomarkers. This highlights the imperative to broadly explore additional factors involved in CRC development, specifically investigating the epigenetic regulation of genes that have not yet been associated with tumorigenesis. Such an exploration contributes to a more holistic understanding, bringing us closer to accurately distinguishing adenomas with malignant potential.  \nEpigenetic changes a","cbCaid9hWBsD9G3G","https://ap.wps.com/l/cbCaid9hWBsD9G3G","pdf",4353867,16,"English","# Abstract\n# Introduction\n# Epigenetic changes and DNA methylation in CRC\n# NOS1 promoter methylation and expression analysis\n# Prognostic and predictive assessment","[{\"question\":\"What question does the study address about NOS1 in colorectal cancer?\",\"answer\":\"The study examines whether NOS1 methylation participates in colorectal carcinogenesis and whether it relates to CRC prognosis.\"},{\"question\":\"How was NOS1 methylation evaluated in tumor and normal tissues?\",\"answer\":\"The authors used promoter methylation assessment on genomic DNA and MassARRAY EpiTYPER methylation analysis, supported by comparative database analyses.\"},{\"question\":\"What prognostic relationship does NOS1 hypermethylation show in CRC patients?\",\"answer\":\"Kaplan-Meier and Cox models indicate NOS1 hypermethylation is significantly associated with better disease-specific survival in CRC.\"}]","NOS1 hypermethylation may participate in the colorectal cancer development and be associated with its prognosis | PDF",1790094767,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1330601d96fdfd9dc08bb248f49b3a9e.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7acc4385f6c095d6d581ea2857539a38.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50bea19edc451735cdce8b5537ab730d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f2702bfa549c434da7ab3e6057de39f.webp",980,1306]